RxDoctor Payments Data

Justin Fraser, MD

Neurological Surgery · Lexington, KYNPI 1427215094

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (39.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Penumbra, Inc. at 47.5% of the total. Reporting peaked in 2019 at $3,767 and has fallen 92.3% since, to $292 in 2024.

$9,573in general payments, 2019–2025

Across 58 payments — averaging $165.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$5K
  • Medical Device Business Services, Inc.$1K
  • Stryker$1K
  • Microvention, Inc.$986
  • Viz.ai, Inc.$440
  • Qapel Medical Inc$262
  • plus $636 from 7 others
$601,043in research payments, 2019–2025

Across 153 payments — averaging $3928.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$337K
  • Stryker$170K
  • Penumbra, Inc.$86K
  • Medical Device Business Services, Inc.$8K

What the payments were for

  • Consulting fees$1952%
  • Speaking & faculty fees$2,40025%
  • Travel & lodging$3,78640%
  • Food & beverage$3,19233%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,573 in reported general payments places this provider in the 70th percentile of 99 neurological surgery providers in Kentucky.

See all neurological surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$110,883
Medicare patients
188
Services billed
624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor14$6,162
ClopidogrelClopidogrel Bisulfate50$334
Prednisone15$36

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →